巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

TransCode Therapeutics

RNAZ
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・TransCode Therapeutics - 延遲價格・最後更新於 14/01 12:14
最高位
2.510
最低位
2.400
開市價
--
前收市價
2.420
成交量(千)
0.34
成交額(百萬)
0.01
買入
--
賣出
--
每手股數
--
市值(百萬)
32.39
市盈率
--
息率
--
差價
--
52週高低
7.000 - 2.350
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
TransCode Therapeutics
證券代碼
RNAZ.US
所屬板塊
Biotechnology
公司業務
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.
發行量
11967074
公司總部
6 Liberty Square, Suite 2382
公司網址
https://www.transcodetherapeutics.com
公司電話
+1 857 837-3099
暫無內容

關於

TransCode Therapeutics(RNAZ.US)所屬的行業板塊為Biotechnology。
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.
詳細公司背景可參考: https://www.transcodetherapeutics.com